Cubist Pharmaceuticals Inc. buy melinda
Start price
17.11.10
/
50%
€16.83
Target price
17.05.11
€20.00
Performance (%)
41.30%
End price
17.05.11
€23.78
Summary
This prediction ended on 17.05.11 with a price of €23.78. The BUY prediction by melinda for Cubist Pharmaceuticals Inc. saw massive gains of 41.30%. melinda has 50% into this predictionPerformance without dividends (%)
Name | 1w | 1m | 1y | 3y |
---|---|---|---|---|
Cubist Pharmaceuticals Inc. | - | - | - | - |
iShares Core DAX® | 1.280% | 1.320% | 13.605% | 15.782% |
iShares Nasdaq 100 | -2.457% | -5.192% | 25.941% | 38.434% |
iShares Nikkei 225® | -2.006% | -1.389% | 8.973% | 6.570% |
iShares S&P 500 | -0.662% | -1.884% | 23.684% | 39.611% |
Comments by melinda for this prediction
In the thread Cubist Pharmaceuticals Inc. diskutieren
PHARMA
cubis Pharma vielversprechende Phase des 30. Juni Cephalosporin zur Behandlung komplizierter Infektionen der Harnwege
(Laufzeit überschritten)
Stopped prediction by melinda for Cubist Pharmaceuticals Inc.
Cubist Pharmaceuticals Inc.
Start price
Target price
Perf. (%)
€48.00
18.09.13
18.09.13
€57.00
27.11.13
27.11.13
4.85%
27.11.13
27.11.13